Skip to main content
. 2018 Oct 31;81(1):193–234. doi: 10.1007/s11538-018-0524-1

Table 3.

Descriptions and dimensions for parameters related to symptomatic treatment and IPT

Parameter Description Dimension
1 / a Days to clear a sensitive infection after treatment T
c Per capita rate of IPT treatment administration T-1
1 / r Time chemoprophylaxis lasts in IPT-treated humans T
1/rs Time chemoprophylaxis lasts in symptomatic treated humans T
b Fraction of asymptomatic infected treated juveniles who become temporarily immune protected 1
bm Fraction of asymptomatic infected treated mature humans who become temporarily immune protected 1
p Efficacy of drugs used to clear resistant infections 1